The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction
Clinical trial NCT06732648 · RECRUITING
Trial details
- NCT number
- NCT06732648
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-07
- Primary completion
- 2027-06-01
- Enrollment
- 725
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.